Update on pleural diseases - 2007

Annals of Thoracic Medicine

Volumn 2, Issue 3, 2007, Pages 128-142

  Bishay, Ayman ^a   Raoof, Suhail ^a   Esan, Adebayo ^a   Sung, Arthur ^a   Wali, Siraj ^b   Lee, Leonard ^a   George, Liziamma ^a   Saleh, Anthony ^a   Baumann, Michael ^c  

^a NEW YORK METHODIST HOSPITAL   (United States)

^b King Khaled National Guard   (Saudi Arabia)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Effusions; Empyema; Mesothelioma; Pleural; Pleurodesis; Pneumothorax; Thoracoscopy; Ultrasound

Indexed keywords

AMINOLEVULINIC ACID; ASBESTOS; FIBRINOLYTIC AGENT; FLUORODEOXYGLUCOSE; OSTEOPONTIN; SILVER NITRATE; STREPTOKINASE; TALC;

ASBESTOSIS; CATHETER; ECHOGRAPHY; EMERGENCY PHYSICIAN; EMERGENCY WARD; EMPYEMA; FLUORESCENCE ANALYSIS; HUMAN; MEDICAL LITERATURE; MORBIDITY; MORTALITY; PLEURA CATHETER; PLEURA DISEASE; PLEURA MESOTHELIOMA; PLEURA TUMOR; PLEURODESIS; PNEUMOTHORAX; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; SURGICAL DRAINAGE; THORACOCENTESIS; THORACOSCOPY;

EID: 34547666706     PISSN: 18171737     EISSN: None     Source Type: Journal    
DOI: 10.4103/1817-1737.33704     Document Type: Review

References (64)

1. Baas P, Triesscheijn M, Burgers S, van Pel R, Stewart F, Aalders M. Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid. Chest 2006;129:718-24.
2. Prosst RL, Winkler S, Boehm E, Gahlen J. Thoracoscopic fluorescence diagnosis (TFD) of pleural malignancies: Experimental studies. Thorax 2002;57:1005-9.
3. Gahlen J, Prosst RL, Pietschmann M, Haase T, Rheinwald M, Skopp G, et al. Laparoscopic fluorescence diagnosis for intra-abdominal fluorescence targeting of peritoneal carcinosis experimental studies. Ann Surg 2002;235:252-60.
4. Chan JK, Monk BJ, Cuccia D, Pham H, Kimel S, Gu M, et al. Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinicacid in a rat model. Gynecol Oncol 2002;87:64-70.
5. Lam S, Palcic B, McLean D, Hung J, Korbelik M, Profio AE. Detection of early lung cancer using low dose Photofrin II. Chest 1990;97:333-7.
6. Kato H, Cortese DA. Early detection of lung cancer by means of hematoporphyrin derivative fluorescence and laser photoradiation. Clin Chest Med 1985;6:237-53.
7. Zellweger M, Grosjean P, Monnier P, van den Bergh H, Wagnières G. Stability of the fluorescence measurement of Foscan in the normal human oral cavity as an indicator of its content in early cancers of the esophagus and the bronchi. Photochem Photobiol 1999;69:605-10.
8. Flores RM, Akhurst T, Gonen M, Zakowski M, Dycoco J, Larson SM, et al. Positron emission tomography predicts survival in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2006;132:763-8.
9. Miller R, Siegmund D. Maximally selected Chi square statistics. Biometrics 1982;38:1011-6.
10. Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: Comparison of CT and MR imaging. AJR Am J Roetgenol 1999;172:1039-47.
11. Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW. FDG-PET predicts survival in patients with malignant pleural mesothelioma. Proc ASCO 2003;22:620.
12. Tayal VS, Nicks BA, Norton HJ. Emergency ultrasound evaluation of symptomatic nontraumatic pleural effusions. Am J Emerg Med 2006;24:782-6.
13. Ma OJ, Mateer JR. Trauma ultrasound examination versus chest radiography in the detection of hemothorax. Ann Emerg Med 1997;29:312-6.
14. Lichenstein D, Hulot JS, Rabiller A, Tostivint I, Mezière G. Feasibility and safety of ultrasound-aided thoracentesis in mechanically ventilated patients. Intensive Care Med 1999;25:955-8.
15. Pass HI, Lott D, Lonardo F, Harbut M, Liu Z, Tang N, et al. Asbestos exposure, pleural mesothelioma and serum osteopontin level. N Engl J Med 2005;353:1564-73.
16. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate and lung cancer. Clin Cancer Res 2001;7:4060-6.
17. Singhal H, Bautista DS, Tonkin KS, O.Malley FP, Tuck AB, Chambers AF, et al. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res 1997;3:605-11.
18. Ding L, Zheng S. Expression and clinical significance of osteopontin in colorectal cancer and liver metastatic tissues. Zhonghua Wai Ke Za Zhi 2002;40:773-5.
19. Ue T, Yokozaki H, Kitadai Y, Yamamoto S, Yasui W, Ishikawa T, et al. Coexpression of osteopontin and CD44v9 in gastric cancer. Int J Cancer 1998;79:127-32.
20. Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, et al. Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer. Clin Cancer Res 2004;10:3474-8.
21. Brakora KA, Lee H, Yusuf R, Sullivan L, Harris A, Colella T, et al. Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer. Gynecol Oncol 2004;93:361-5.
22. Kim JH, Skates SJ, Uede T, Wo ng KK, Schorge JO, Feltmate CM, et al. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA 2002;287:1671-9.
23. Denhardt D. Osteopontin expression correlates with melanoma invasion. J Invest Dermatol 2005;124:16-8.
24. Cullen, MR. Serum Osteopontin Levels-Is it time to screen asbestos-exposed workers for pleural mesothelioma? N Engl J Med 2005;353:1617-8.
25. Maskell NA, Davis CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, et al. UK controlled trial of intrapleural streptokinase for pleural infection, multicenter intrapleural sepsis trial (MIST 1). N Engl J Med 2005;352:865-74.
26. Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med 1980;69:507-12.
27. Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999;160:1682-7.
28. Maskell NA, et al. Effusions from parapneumonic infection and empyema. In: Light RW, Lee YC, editors. Textbook of pleural diseases. Arnold: London; 2003. p. 310-28.
29. Colice GL, Curtis A, Deslauriers J, Heffner J, Light R, Littenberg B, et al. Medical and surgical treatment of parapneumonic effusions: An evidence based guideline. Chest 2000;118:1158-71.
30. Davies CW, Gleeson FV, Davies RJ; Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of pleural infection. Thorax 2003;58(suppl):ii18-ii28.
31. Zhu Z, Hawthorne ML, Guo Y, Drake W, Bilaceroglu S, Misra HL, et al. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest 2006;129:1577-83.
32. Tokuda Y, Matsushima D, Stein GH, Miyagi S. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: A meta-analysis. Chest 2006;129:783-90.
33. Davies RJ, Traill ZC, Gleeson FV. Randomized controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997;52:416-21.
34. Tuncozgur B, Ustunsoy H, Sivrikoz MC, Dikensoy O, Topal M, Sanli M, et al. Intrapleural urokinase in the management of parapneumonic empyema: A randomized controlled trial. Int J Clin Pract 2001;55:658-60.
35. Temes RT, Follis F, Kessler RM, Pett SB, Wernly JA. Intrapleural fibrinolytics in management of empyema thoracis. Chest 1996;110:102-6.
36. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, et al. U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005;352:865-74.
37. Paschoalini Mda S, Vargas FS, Marchi E, Pereira JR, Jatene FB, Antonangelo L, et al. Prospective randomized trial of silver nitrate vs. talc slurry in pleurodesis for symptomatic malignant pleural effusions. Chest 2005;128:684-9.
38. Zimmer PW, Hill M, Casey K, Harvey E, Low DE. Prospective randomized trial of talc slurry vs. bleomycin in pleurodesis for symptomatic malignant pleural effusions [Article in Spanish]. Chest 1997;112:430-4.
39. Leone RR, Corsetti HI, Vicario GP. Hidroxido de sodio intrapleural para el control del derrame metastatico. Prensa Med Argent 1982;69:764-7.
40. Vargas FS, Teixeira LR, Antonangelo L, Vaz MA, Carmo AO, Marchi E, et al. Experimental pleurodesis in rabbits induced by silver nitrate or talc [Article in Spanish]. Chest 2001;119:1516-20.
41. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994;120:56-64.
42. Kennedy L, Rusch VW, Strange C, Ginsberg RJ, Sahn SA. Pleurodesis using talc slurry. Chest 1994;106:342-6.
43. Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G, Davies RJ. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med 2004;170:377-82.
44. Brant A, Eaton T. Serious complications with talc slurry pleurodesis. Respirology 2001;6:181-5.
45. Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: A prospective cohort study. Lancet 2007;369:1535-9.
46. Devanand A, Koh MS, Ong TH, Low SY, Phua GC, Tan KL, et al. Simple aspiration versus chest tube insertion in the management of primary spontaneous pneumothorax: A systemic review. Respir Med 2004;98:579-90.
47. Kjaergard H. Spontaneous pneumothorax in the apparently healthy. Acta Med Scand Suppl 1932;43:1-159.
48. Melton LJ, Hepper NC, Offord KP. Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950-1974. Is Rev Respir Dis 1979;29:1379-82.
49. Henry M, Arnold T, Harvey J. BTS guidelines for the management of spontaneous pneumothorax. Thorax 2003;58 (suppl):ii39-ii52.
50. Baumann MH, Strange C, Heffner JE, Light R, Kirby TJ, Klein J, et al. Management of spontaneous pneumothorax: An american college of chest physicians delphi consensus statement. Chest 2001;119:590-602.
51. Andrivet P, Djedaini K, Teboul JL, Brochard L, Dreyfuss D. Spontaneous pneumothorax: Comparison of thoracic drainage vs. immediate or delayed needle aspiration. Chest 1995;106:335-9.
52. Harvey J, Prescott RJ. Simple aspiration versus intercostal tube drainage for spontaneous pneumothorax in patients with normal lungs. British Thoracic Society Research Committee. BMJ 1994;309:1338-9.
53. Noppen M, Alexander P, Drisen P, Slabbynck H, Verstraeten A. Manual aspiration versus chest tube drainage in first episodes of primary spontaneous pneumothorax. Am J Respir Crit Care Med 2002;165:1240-4.
54. Tremblay A, Michaud G. Single-center experience with 250 tunneled pleural catheter insertions for malignant pleural effusion. Chest 2006;129:362-8.
55. Brubacher S, Gobel BH. Use of the Pleurx pleural catheter for the management of malignant pleural effusions. Clin J Oncol Nurs 2003;7:35-8.
56. Musani AI, Haas AR, Seijo L, Wilby M, Sterman DH. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration 2004;71:559-66.
57. Putnam JB, Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999;86:1992-9.
58. Putnam JB Jr, Walsh GL, Swisher SG, Roth JA, Suell DM, Vaporciyan AA, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000;69:369-75.
59. Pine GW, Gant MJ, Washam CL, Sterman DH. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest 2001;119:1641-6.
60. Kuzdzał J, Sładek K, Wasowski D, Soja J, Szlubowski A, Reifland A, et al. Talc powder vs. doxycycline in the control of malignant pleural effusion: A prospective, randomized trial. Med Sci Monit 2003;9:PI54-9.
61. Hartman DL, Gaither JM, Kesler KA, Mylet DM, Brown JW, Mathur PN. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg 1993;105:743-8.
62. Bydder S, Phillips M, Joseph DJ, Cameron F, Spry NA, DeMelker Y, et al. A randomized trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer 2004;91:9-10.
63. Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer 1993;72:389-93.
64. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995;108:754-8.